Medicamen Biotech consolidated net profit declines 46.01% in the December 2023 quarter

Sales rise 30.69% to Rs 46.50 crore

Net profit of Medicamen Biotech declined 46.01% to Rs 2.03 crore in the quarter ended December 2023 as against Rs 3.76 crore during the previous quarter ended December 2022. Sales rose 30.69% to Rs 46.50 crore in the quarter ended December 2023 as against Rs 35.58 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales46.5035.58 31 OPM %10.5216.53 -PBDT5.085.82 -13 PBT3.274.22 -23 NP2.033.76 -46

Powered by Capital Market - Live News